Donald J. Hayden Jr., Director at REGENXBIO Inc. (RGNX), sold 30,000 shares at $45.60 ($1.4M) on 2020-01-14, disclosed to the SEC on 2020-01-16.
Open-market sale of $1.4M RGNX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RGNX | SELL | 2020-02-07 | $100K | — | Filing → |
| RGNX | SELL | 2020-01-21 | $160K | — | Filing → |
| INSM | SELL | 2019-04-11 | $415K | — | Filing → |